BRIEF-Cipher pharmaceuticals announces Ozenoxacin accepted for review by Health Canada

Tue Jul 12, 2016 7:30am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 12 (Reuters) - Cipher Pharmaceuticals Inc

* Cipher Pharmaceuticals announces ozenoxacin accepted for review by Health Canada

* Cipher Pharmaceuticals Inc says that its new drug submission for ozenoxacin has been accepted for review by Health Canada Source text for Eikon: Further company coverage: